SCHEMBL8094910

SCHEMBL8094910

N#Cc1cc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccc(F)cc2)nc1OCC1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.46
PTGS1 P23219 1/20 0.46
CDK2 P24941 10/20 0.44
CDK1 P06493 7/20 0.44
CCNB1 P14635 5/20 0.44
CCNT1 O60563 4/20 0.44
CDK7 P50613 4/20 0.44
CDK9 P50750 4/20 0.44
CCNH P51946 4/20 0.44
CDK5 Q00535 4/20 0.44
CNR1 P21554 6/20 0.44
CCNA2 P20248 6/20 0.43
CCNA1 P78396 5/20 0.43
CNR2 P34972 1/20 0.43
KDM1A O60341 1/20 0.42
CCNB2 O95067 2/20 0.41
CCNB3 Q8WWL7 2/20 0.41
ROCK2 O75116 1/20 0.41
CDK4 P11802 1/20 0.41
CCND1 P24385 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8101167 0.99 PTGS2 (0.45) PTGS2PTGS1CDK2CDK1CCNB1
SCHEMBL8098730 0.97 CNR1 (0.44) PTGS2PTGS1CDK2CDK1CCNB1
SCHEMBL8099746 0.95 CNR1 (0.46) PTGS2PTGS1CDK1CNR1CNR2
SCHEMBL8101755 0.91 PTGS2 (0.58) PTGS2PTGS1CDK2CDK1CCNB1
SCHEMBL8101431 0.90 PTGS2 (0.56) PTGS2PTGS1CNR1CNR2KDM1A
SCHEMBL8093970 0.88 PTGS2 (0.54) PTGS2PTGS1CNR1CNR2KDM1A
SCHEMBL8099978 0.86 PTGS2 (0.52) PTGS2PTGS1CNR1CNR2KDM1A
SCHEMBL8094551 0.84 CNR1 (0.49) PTGS2PTGS1CNR1CNR2
SCHEMBL8094996 0.84 PTGS2 (0.48) PTGS2PTGS1CDK1CNR1CNR2
SCHEMBL8086461 0.84 CNR1 (0.61) PTGS2PTGS1CDK1CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808304-B1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-12-27 EP disclosed
EP-0808304-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-11-26 EP disclosed
WO-1996024584-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-15 WO disclosed